New imaging agents aim to spot colorectal cancer spread
NCT ID NCT03275974
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 24 times
Summary
This early-phase study tested whether special PET scans using 11C-glutamine and 18F-FSPG can better detect tumors in people with advanced colorectal cancer that has spread. Six adults with a specific genetic type (RAS wild-type) were enrolled. The goal was to see if these new imaging methods work as well as or better than standard CT or MRI scans.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RAS WILD TYPE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.